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Abstract
Cognitive enhancement and so-called ’neuroenhancement’ refer to the use of
pharmaceuticals, natural products and devices by healthy individuals to improve
cognitive and neuro abilities above what is considered normal or average for the human
body. Neuroenhancement has generated discussion and controversy in academic
and public spheres alike1,2. We conducted a scoping literature review pertaining
to the neuroenhancement of healthy individuals with the intention of helping to
inform future research directions and discussions with respect to neuroenhancement.
We drew literature from the following databases: JSTOR, ScienceDirect, PubMed,
EBSCO-Academic Search Complete, Web of Science and Scopus (Elsevier). In order
to meet inclusion criteria, articles had to be available in full-text English and address
neuroenhancement in a non-rehabilitative fashion. This led to in-depth thematic
analysis of 61 articles. We found that the identified ethical issues existed on three levels:
individual, institutional and societal. Additionally, we found that non-pharmaceutical
modes of neuroenhancement were largely excluded from discussion. The issues
that were deemed most important pertained to safety, efficacy, and the influence on
identity that neuroenhancements could have. Finally, implications and future research
directions are discussed.
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